UQUIFA Email Format
Pharmaceutical ManufacturingCatalonia, Spain201-500 Employees
Uquifa operates as a contract development and manufacturing organization for small-molecule pharmaceuticals. The company emphasizes high quality and speed, supporting clients through the full lifecycle of New Chemical Entity programs—from preclinical work to commercial manufacturing. Headquartered in the Barcelona area of Catalonia, Spain, Uquifa maintains a European and North American footprint to serve global customers. Its facilities have been inspected and approved by major regulatory bodies, including the US FDA, Health Canada, EMA, PMDA, Korean FDA, ANVISA, and COFEPRIS. The group maintains an API portfolio with more than 150 active DMFs filed and 26 COS approved, reflecting its depth of regulatory and development experience in small-molecule manufacturing. In 2025, Uquifa announced participation in Chemspec Europe 2025 in Cologne, underscoring ongoing engagement with the broader pharmaceutical community.